Welcome to our dedicated page for Aurora Spine news (Ticker: ASAPF), a resource for investors and traders seeking the latest updates and insights on Aurora Spine stock.
Aurora Spine Corporation develops and manufactures minimally invasive spinal implants and interventional pain management technologies for spinal surgery. News about ASAPF commonly covers product launches, patent issuances and commercialization updates across the company's spine portfolio, including DEXA Technology bone density-matched implants, ZIP implants, SiLO systems, Hydra A.E.R.O. facet fusion products and Aurora Biologics.
Recurring updates also include financial results, sales-force and product-adoption commentary, medical meeting participation and intellectual-property expansion through U.S. patents. Company releases emphasize implant designs that match patient bone density, fusion and motion-preservation applications, and integrated biologic support for spinal fusion procedures.
Aurora Spine has scheduled a conference call to update investors and discuss its first quarter fiscal 2024 financial results. The call will take place on May 14, 2024, at 11:00 a.m. Eastern Time. Interested parties can access the call via dial-in or webcast. A replay will be available for a time.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.